Geneos Wealth Management’s Sylvamo SLVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.56K Buy
109
+46
+73% +$1.71K ﹤0.01% 2743
2026
Q2
$2.38K Hold
63
– – ﹤0.01% 2305
2026
Q1
$2.66K Buy
63
+11
+21% +$515 ﹤0.01% 2273
2025
Q4
$2.5K Hold
52
– – ﹤0.01% 2285
2025
Q3
$2.3K Sell
52
-239
-82% -$11.1K ﹤0.01% 2296
2025
Q2
$14.6K Sell
291
-7
-2% -$394 ﹤0.01% 2167
2025
Q1
$20K Buy
298
+68
+30% +$4.96K ﹤0.01% 1949
2024
Q4
$18.2K Hold
230
– – ﹤0.01% 1769
2024
Q3
$19.7K Buy
230
+149
+184% +$11.1K ﹤0.01% 1560
2024
Q2
$5.56K Hold
81
– – ﹤0.01% 1696
2024
Q1
$5K Hold
81
– – ﹤0.01% 1708
2023
Q4
$3.98K Hold
81
– – ﹤0.01% 1778
2023
Q3
$3.56K Sell
81
-31
-28% -$1.33K ﹤0.01% 1832
2023
Q2
$4.53K Hold
112
– – ﹤0.01% 1764
2023
Q1
$5.18K Hold
112
– – ﹤0.01% 1718
2022
Q4
$5.44K Sell
112
-54
-33% -$2.59K ﹤0.01% 1688
2022
Q3
$5K Sell
166
-56
-25% -$2.13K ﹤0.01% 1700
2022
Q2
$7K Sell
222
-3
-1% -$126 ﹤0.01% 2099
2022
Q1
$7K Buy
+225
New +$7.47K ﹤0.01% 2246

Other funds holding SLVM

Geneos Wealth Management's SLVM Position: Q3 2026 in Review

Geneos Wealth Management increased its Sylvamo (SLVM) stake by 73% in Q3 2026, buying an estimated $1.71K and bringing the position to 109 shares worth $3.56K. The position accounts for ﹤0.01% of the portfolio, ranked #2743.

Geneos Wealth Management first reported a position in SLVM in Q1 2022 and has held it in 19 quarters since. The position peaked at $20K in Q1 2025. 303 funds tracked by Wall St. Rank hold SLVM as of Q3 2026.

  • Geneos Wealth Management held 109 shares of Sylvamo worth $3.56K as of Q3 2026.
  • Geneos Wealth Management bought 46 Sylvamo shares in Q3 2026, an estimated $1.71K.
  • Sylvamo made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2743 holding.
  • Geneos Wealth Management first reported a position in Sylvamo in Q1 2022 and has held it in 19 quarters since.
  • Geneos Wealth Management's Sylvamo position peaked at $20K in Q1 2025.
  • 303 funds tracked by Wall St. Rank held Sylvamo as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.